As of 2025-10-15, the Relative Valuation of Novacyt SA (ALNOV.PA) is (12.72) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.46 EUR, the upside of Novacyt SA based on Relative Valuation is -2853.1%.
The range of the Relative Valuation is (8.35) - (11.51) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 35.3x | 33.5x |
| Forward P/E multiples | 18.6x - 26.7x | 25.6x |
| Fair Price | (8.35) - (11.51) | (12.72) |
| Upside | -1907.4% - -2591.3% | -2853.1% |
| Date | P/E |
| 2025-10-14 | -1.07 |
| 2025-10-13 | -1.12 |
| 2025-10-10 | -1.12 |
| 2025-10-09 | -1.09 |
| 2025-10-08 | -1.09 |
| 2025-10-07 | -1.11 |
| 2025-10-06 | -1.08 |
| 2025-10-03 | -1.10 |
| 2025-10-02 | -1.12 |
| 2025-10-01 | -1.13 |
| 2025-09-30 | -1.11 |
| 2025-09-29 | -1.13 |
| 2025-09-26 | -1.05 |
| 2025-09-25 | -1.09 |
| 2025-09-24 | -1.06 |
| 2025-09-23 | -1.08 |
| 2025-09-22 | -1.08 |
| 2025-09-19 | -1.07 |
| 2025-09-18 | -1.05 |
| 2025-09-17 | -1.07 |
| 2025-09-16 | -1.08 |
| 2025-09-15 | -1.10 |
| 2025-09-12 | -1.07 |
| 2025-09-11 | -1.10 |
| 2025-09-10 | -1.11 |
| 2025-09-09 | -1.03 |
| 2025-09-08 | -1.04 |
| 2025-09-05 | -1.05 |
| 2025-09-04 | -1.06 |
| 2025-09-03 | -1.04 |
| 2025-09-02 | -1.05 |
| 2025-09-01 | -1.08 |
| 2025-08-29 | -1.10 |
| 2025-08-28 | -1.10 |
| 2025-08-27 | -1.10 |
| 2025-08-26 | -1.08 |
| 2025-08-25 | -1.12 |
| 2025-08-22 | -1.10 |
| 2025-08-21 | -1.12 |
| 2025-08-20 | -1.09 |
| 2025-08-19 | -1.10 |
| 2025-08-18 | -1.13 |
| 2025-08-15 | -1.10 |
| 2025-08-14 | -1.14 |
| 2025-08-13 | -1.21 |
| 2025-08-12 | -1.03 |
| 2025-08-11 | -1.03 |
| 2025-08-08 | -1.03 |
| 2025-08-07 | -1.04 |
| 2025-08-06 | -1.04 |